πŸ“Š This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Astex Pharmaceuticals

1.1 - Company Overview

Astex Pharmaceuticals Logo

Astex Pharmaceuticals

Headquarter: United Kingdom
Founded: 20XXπŸ”’
Employees: 100-500πŸ”’
🌐 Website

Company description

  • Provider of novel small-molecule therapeutics discovery and development using its pioneering fragment-based drug discovery platform, Pyramidβ„’. The UK-based company has built a pipeline of molecularly-targeted oncology drugs, with three in clinical trials and others in discovery and pre-clinical stages.

Products and services

πŸ”’

Key contacts

πŸ”’
πŸ”’

Financial details

πŸ”’

1.2 - Competitors and similar companies to Astex Pharmaceuticals

Lobe Sciences Logo

Lobe Sciences

HQ: Canada Website
  • Description: Provider of life sciences focused on transformational medicine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lobe Sciences company profile β†’
NeuroSigma Logo

NeuroSigma

HQ: United States Website
  • Description: Provider of trigeminal nerve stimulation (TNS) medical devices and therapies for neurologic and psychiatric disorders. The company commercializes its TNS technology with a pipeline targeting epilepsy, depression, ADHD, and PTSD. Products include the Monarch eTNS System, a non-drug treatment device for pediatric ADHD used during sleep under caregiver supervision.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NeuroSigma company profile β†’
Stellate Logo

Stellate

HQ: Canada Website
  • Description: Provider of networking, database, recording, review, and analysis systems for electrical activity from the brain, serving EEG laboratories, epilepsy monitoring units, sleep laboratories, and intensive care units; engaged in the development, design, and manufacture of products for brain activity recording and analysis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Stellate company profile β†’
Compass Pathways Logo

Compass Pathways

HQ: United Kingdom Website
  • Description: Provider of psilocybin-based mental health therapies and research for treatment-resistant depression, PTSD, and anorexia nervosa. Offers COMP360 psilocybin treatment administered with psychological support, a therapist training programme, a Discovery Center for preclinical studies, and support for investigator-initiated studies, conducting clinical trials and research on psilocybin therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Compass Pathways company profile β†’
Vernalis Logo

Vernalis

HQ: United Kingdom Website
  • Description: Provider of fragment- and structure-based drug discovery, research collaborations with pharmaceutical, biotechnology and academic partners, and KNIME open-source software nodes for data access, cheminformatics and structural informatics; develops Chk1 and Hsp90 inhibitors. A revenue-generating development-stage pharmaceutical company advancing promising product candidates along a commercially focused path to market.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vernalis company profile β†’
πŸ”’

2.M&A buyers

2.1 Potential strategic acquirers in the sector

πŸ”’
πŸ”’
πŸ”’
πŸ”’ View all strategic buyers with complete profiles
Start Free Trial β†’

2.2 - Strategic buyer groups for Astex Pharmaceuticals

πŸ”’

Buyer group 1: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 2: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”’

Buyer group 3: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ

●● companies
Description: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
Key Products: β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ
πŸ”’ View all companies in this group
Request Free Trial Now β†’
πŸ”“ Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β†’

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Astex Pharmaceuticals

2.2 - Growth funds investing in similar companies to Astex Pharmaceuticals

πŸ”’ View all growth equity funds with complete profiles
Start Free Trial β†’

4 - Top valuation comps for Astex Pharmaceuticals

4.2 - Public trading comparable groups for Astex Pharmaceuticals

πŸ”“ Unlock all public trading comparable groups with complete valuation data
Start Free Trial β†’

4.3 - M&A Transactions similar to Astex Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
πŸ”’ View all M&A transactions with complete deal terms
Request Free Trial Now β†’

Frequently Asked Questions

About Astex Pharmaceuticals

What does Astex Pharmaceuticals do?

Astex Pharmaceuticals is a provider of novel small-molecule therapeutics discovery and development using its pioneering fragment-based drug discovery platform, Pyramidβ„’. The UK-based company has built a pipeline of molecularly-targeted oncology drugs, with three in clinical trials and others in discovery and pre-clinical stages.

Who are Astex Pharmaceuticals's competitors?

Astex Pharmaceuticals's competitors and similar companies include Lobe Sciences, NeuroSigma, Stellate, Compass Pathways, and Vernalis.

Where is Astex Pharmaceuticals headquartered?

Astex Pharmaceuticals is headquartered in United Kingdom.

How many employees does Astex Pharmaceuticals have?

Astex Pharmaceuticals has 1,000 employees πŸ”’.

When was Astex Pharmaceuticals founded?

Astex Pharmaceuticals was founded in 2010 πŸ”’.

What sector and industry vertical is Astex Pharmaceuticals in?

Astex Pharmaceuticals is in the Enterprise Software πŸ”’ sector and industry

M&A Buyers & Acquirers for Astex Pharmaceuticals

Who are the top strategic acquirers in Astex Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Astex Pharmaceuticals's sector include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Which M&A buyer groups are most relevant for Astex Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Astex Pharmaceuticals include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ , β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Financial Investors investing in Astex Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Astex Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Astex Pharmaceuticals's sector and industry vertical include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Who are the top buyout funds acquiring in Astex Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Astex Pharmaceuticals's sector and industry vertical include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Who are the top growth equity funds investing in companies in Astex Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Astex Pharmaceuticals include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Valuation benchmarks of companies in Astex Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Astex Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Astex Pharmaceuticals include β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ, and β–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆβ–ˆ πŸ”’.

Which are the key trading comparable groups for Astex Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Astex Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Astex Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Astex Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Astex Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Astex Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Astex Pharmaceuticals

Launch login modal Launch register modal